A detailed history of Ae Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ae Wealth Management LLC holds 58,242 shares of BMY stock, worth $3.35 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
58,242
Previous 108,803 46.47%
Holding current value
$3.35 Million
Previous $4.52 Million 33.29%
% of portfolio
0.03%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $2.01 Million - $2.62 Million
-50,561 Reduced 46.47%
58,242 $3.01 Million
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $641,343 - $844,342
15,934 Added 17.16%
108,803 $4.52 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $10.3 Million - $11.7 Million
-215,491 Reduced 69.88%
92,869 $5.04 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $2.51 Million - $3 Million
51,796 Added 20.19%
308,360 $15.8 Million
Q3 2023

Oct 11, 2023

BUY
$57.89 - $64.73 $2.72 Million - $3.04 Million
46,937 Added 22.39%
256,564 $14.9 Million
Q2 2023

Jul 10, 2023

BUY
$63.71 - $70.74 $1.36 Million - $1.51 Million
21,385 Added 11.36%
209,627 $13.4 Million
Q1 2023

Apr 14, 2023

SELL
$65.71 - $74.53 $343,006 - $389,046
-5,220 Reduced 2.7%
188,242 $13 Million
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $628,714 - $744,487
-9,181 Reduced 4.53%
193,462 $13.9 Million
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $4,113 - $2.43 Million
-31,645 Reduced 13.51%
202,643 $14.4 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $32,025 - $35,271
441 Added 0.19%
234,288 $18 Million
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $362,363 - $434,505
5,894 Added 2.59%
233,847 $17.1 Million
Q4 2021

Jan 20, 2022

BUY
$53.63 - $62.52 $2.27 Million - $2.65 Million
42,364 Added 22.83%
227,953 $14.2 Million
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $219,402 - $257,001
3,708 Added 2.04%
185,589 $11 Million
Q2 2021

Jul 21, 2021

BUY
$61.91 - $67.42 $794,119 - $864,796
12,827 Added 7.59%
181,881 $12.2 Million
Q1 2021

Apr 27, 2021

SELL
$59.34 - $66.74 $285,425 - $321,019
-4,810 Reduced 2.77%
169,054 $10.7 Million
Q4 2020

Feb 01, 2021

BUY
$57.74 - $65.43 $880,130 - $997,349
15,243 Added 9.61%
173,864 $10.8 Million
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $841,062 - $932,007
-14,645 Reduced 8.45%
158,621 $9.56 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $4.48 Million - $5.24 Million
81,800 Added 89.43%
173,266 $10.2 Million
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $150,892 - $219,282
3,252 Added 3.69%
91,466 $5.1 Million
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $1.39 Million - $1.82 Million
28,339 Added 47.33%
88,214 $5.66 Million
Q3 2019

Nov 05, 2019

SELL
$42.77 - $50.71 $129,208 - $153,194
-3,021 Reduced 4.8%
59,875 $3.04 Million
Q2 2019

Jul 22, 2019

BUY
$44.62 - $49.34 $1.09 Million - $1.2 Million
24,399 Added 63.38%
62,896 $2.85 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $312,049 - $372,080
6,916 Added 21.9%
38,497 $1.84 Million
Q4 2018

Feb 15, 2019

BUY
$48.76 - $63.23 $156,665 - $203,157
3,213 Added 11.33%
31,581 $1.64 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $53,203 - $60,009
964 Added 3.52%
28,368 $1.76 Million
Q2 2018

Aug 15, 2018

SELL
$50.53 - $62.98 $17,079 - $21,287
-338 Reduced 1.22%
27,404 $1.52 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $205,226 - $236,256
-3,425 Reduced 10.99%
27,742 $1.76 Million
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $1.06 Million - $1.16 Million
17,682 Added 131.12%
31,167 $1.91 Million
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $228,817 - $264,074
4,143 Added 44.35%
13,485 $860,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,342
9,342 $521,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.